U.S. pharma large copyright scrapped two experimental weight loss pills previous 12 months—a once-everyday capsule, lotiglipron, because of elevated liver enzymes in addition to a two times-each day tablet, danuglipron, on account of strong Negative effects—but CEO Albert Bourla has explained the company is set to “play and get” inside the